Filter results
You can narrow down the results using the filters
Audience
Topics
Our work
Year
475 results
-
AHPC statement on measles
The Australian Health Protection Committee (AHPC) is concerned about the recent increase in measles cases reported in Australia, with outbreaks identified in several states and territories. -
AHPC Statement – Appreciation Statement for Professor Paul Kelly
The Australian Health Protection Committee (AHPC) statement of Appreciation for Professor Paul Kelly leadership and contribution. -
Have your say on Australia’s Sexually Transmissible Infections (STI) Strategy
You can help guide how we continue to improve sexual health in Australia by providing feedback on our draft National STI Strategy. Consultation is now open until 20 December 2024. -
$251.7m to establish an independent Australian Centre for Disease Control (CDC)
The Australian Government is investing $251.7 million to deliver Australia’s Centre for Disease Control (CDC). -
World AIDS Day 2023
World AIDS Day, held on 1 December each year, helps raise awareness about HIV and AIDS. This year’s theme is ‘Inclusion. Respect. Equity.’ -
AHPPC statement – End of COVID-19 emergency response
On 20 October 2023, Australia’s Chief Medical Officer declared that COVID-19 is no longer a Communicable Disease Incident of National Significance (CDINS) following the end of winter in Australia. The Australian Health Protection Principal Committee (AHPPC) supports this declaration. -
AHPPC statement – Advice to support safe cruising
The Australian Health Protection Principal Committee (AHPPC) agreed at its meeting on 16 August 2023 to rescind the current Communicable Diseases Network Australia (CDNA) National Guidelines for Cruising in Australia (the CDNA Guidelines). The CDNA Guidelines will be rescinded as of 25 August 2023. -
Consultation open for development of the Fourth National Hepatitis B Strategy 2023–2030 and Sixth National Hepatitis C Strategy 2023–2030
We are seeking feedback from health professionals, researchers, community organisations and people living with or affected by hepatitis B or hepatitis C. -
Common Operating Picture discontinuation
The Coronavirus (COVID-19) Common Operating Picture (COP) has been discontinued. -
Young Deadly Free – Safe sex and sexual health
Practising safe sex is everyone's responsibility. Reduce the risk of infection by using condoms and getting regular sexual health checks. -
New provider resources about influenza vaccination for First Nations’ people
Vaccination providers play an important role in offering influenza vaccines for First Nations people. New resources are now available to support vaccination providers in having conversations with First Nations’ families. -
ATAGI recommendations on use of the Moderna bivalent (Original/Omicron BA.4/5) COVID-19 vaccine
Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of the Moderna bivalent (Original/Omicron BA.4/5) COVID-19 vaccine. -
ATAGI recommendations on use of the Pfizer bivalent (Original/Omicron BA.4/5) COVID-19 vaccine
Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of the Pfizer bivalent (Original/Omicron BA.4/5) COVID-19 vaccine. -
Changes to HPV vaccine dose schedule for young Australians
From 6 February 2023 the human papillomavirus (HPV) vaccine schedule will become a single dose schedule. Catch-up under the National Immunisation Program (NIP) will also be extended to all Australians 25 years and under. -
Mandatory reporting of Japanese encephalitis virus vaccines to the Australian Immunisation Register began on 21 December 2022
From 21 December 2022, vaccination providers must report all Japanese encephalitis virus (JEV) vaccines administered to the Australian Immunisation Register (AIR). -
Ozzie vs Mozzie
The Australian Government has launched a new advertising campaign to encourage Australians to take simple steps to protect themselves against mosquito borne viruses, like Japanese Encephalitis Virus. -
ATAGI recommendations for a booster dose of the paediatric Pfizer COVID-19 vaccine in children aged 5 to 11 years
Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on Pfizer booster doses for children aged 5 to 11 years. -
Prime Minister’s update following the National Cabinet meeting 30 September 2022
Read the Prime Minister’s update following the National Cabinet meeting on 30 September 2022. -
ATAGI recommend the COVID-19 vaccination for some children aged 6 months to under 5 years
Australia’s immunisation experts, the Australian Technical Advisory Group on Immunisation, recommend COVID-19 vaccination for some children aged 6 months to under 5 years who have an increased risk of getting very sick from COVID-19. The COVID-19 vaccination will help reduce this risk. -
New weekly COVID-19 trends reporting
The Australian Government is now providing weekly trend reporting of COVID-19 case numbers and statistics. -
ATAGI update following COVID-19 meeting – 7 September 2022
An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their meeting on 7 September 2022. ATAGI are now meeting every fortnight on COVID-19 related issues. -
ATAGI statement on use of the Moderna bivalent Original/Omicron vaccine
A statement from the Australian Technical Advisory Group on Immunisation (ATAGI) regarding COVID-19 Moderna Spikevax Bivalent Original/Omicron BA.1 vaccine. -
AHPPC Statement – reduced isolation period for COVID-19 cases
The Australian Health Protection Principal Committee (AHPPC) notes the need for a proportionate approach to isolation for those with COVID‑19 infections at this stage of the pandemic. -
ATAGI update following weekly COVID-19 meeting – 31 August 2022
An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 31 August 2022. -
National Cabinet Statement on COVID-19 settings
The following statement was released following the conclusion of National Cabinet on Wednesday 31 August 2022.